Advances in molecular imaging for breast cancer detection and characterization

Por Specht, Jennifer M, Mankoff, David A
Publicado em 2012

Blood Flow-Metabolism Mismatch: Good for the Tumor, Bad for the Patient

Por Mankoff, David A., Dunnwald, Lisa K., Partridge, Savannah C., Specht, Jennifer M.
Publicado em 2009

Circulating Carbonic Anhydrase IX and Antiangiogenic Therapy in Breast Cancer

Por Brown-Glaberman, Ursa, Marron, Marilyn, Chalasani, Pavani, Livingston, Robert, Iannone, Maria, Specht, Jennifer, Stopeck, Alison T.
Publicado no Dis Markers (2016)

Adjuvant continuous metronomic adriamycin+cyclophosphamide followed by weekly nab-paclitaxel for high-risk early stage breast cancer

Por Cho, Eunpi, Wu, Qian, Rubinstein, Lena, Linden, Hannah, Gralow, Julie, Specht, Jennifer, Gadi, Vijayakrishna, Ellis, Georgiana
Publicado no Breast J (2018)

Dendritic Cells Retrovirally Transduced with a Model Antigen Gene Are Therapeutically Effective against Established Pulmonary Metastases

Por Specht, Jennifer M., Wang, Gang, Do, My T., Lam, John S., Royal, Richard E., Reeves, Mark E., Rosenberg, Steven A., Hwu, Patrick
Publicado em 1997

Kinetic Analysis of (18)F-Fluoride PET Images of Breast Cancer Bone Metastases

Por Doot, Robert K., Muzi, Mark, Peterson, Lanell M., Schubert, Erin K., Gralow, Julie R., Specht, Jennifer M., Mankoff, David A.
Publicado em 2010

Adjuvant Metronomic CMF in a Contemporary Breast Cancer Cohort: What’s Old is New

Por Cho, Eunpi, Schwemm, Ann, Rubinstein, Lena, Stevenson, Phillip, Gooley, Ted A., Ellis, Georgiana, Specht, Jennifer M., Livingston, Robert B., Linden, Hannah M., Gadi, Vijayakrishna K.
Publicado no Clin Breast Cancer (2015)

Surveillance for second breast cancer events in women with a personal history of breast cancer using breast MRI: a systematic review and meta-analysis

Por Haas, Cameron B., Nekhlyudov, Larissa, Lee, Janie M., Javid, Sara H., Bush, Mary, Johnson, Dianne, Gleason, Timothy, Kaufman, Cary, Specht, Jennifer, Stitham, Sean, Wernli, Karen J.
Publicado no Breast Cancer Res Treat (2020)

Feasibility study of FDG PET as an indicator of early response to aromatase inhibitors and trastuzumab in a heterogeneous group of breast cancer patients

Por Kurland, Brenda F, Gadi, Vijayakrishna K, Specht, Jennifer M, Allison, Kimberly H, Livingston, Robert B, Rodler, Eve T, Peterson, Lanell M, Schubert, Erin K, Chai, Xiaoyu, Mankoff, David A, Linden, Hannah M
Publicado em 2012

Test–Retest Reproducibility of (18)F-FDG PET/CT Uptake in Cancer Patients Within a Qualified and Calibrated Local Network

Por Kurland, Brenda F., Peterson, Lanell M., Shields, Andrew T., Lee, Jean H., Byrd, Darrin W., Novakova-Jiresova, Alena, Muzi, Mark, Specht, Jennifer M., Mankoff, David A., Linden, Hannah M., Kinahan, Paul E.
Publicado no J Nucl Med (2019)

Association Between Serial Dynamic Contrast-Enhanced MRI and Dynamic (18)F-FDG PET Measures in Patients undergoing Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer

Por Partridge, Savannah C., Vanantwerp, Risa K., Doot, Robert K., Chai, Xiaoyu, Kurland, Brenda F., Eby, Peter R., Specht, Jennifer M., Dunnwald, Lisa K., Schubert, Erin K., Lehman, Constance D., Mankoff, David A.
Publicado em 2010

A Phase 2 Study of 16α-[(18)F]-fluoro-17β-estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC)

Por Peterson, Lanell M., Kurland, Brenda F., Schubert, Erin K., Link, Jeanne M., Gadi, V.K., Specht, Jennifer M., Eary, Janet F., Porter, Peggy, Shankar, Lalitha K., Mankoff, David A., Linden, Hannah M.
Publicado em 2013

PET TUMOR METABOLISM IN LOCALLY ADVANCED BREAST CANCER PATIENTS UNDERGOING NEOADJUVANT CHEMOTHERAPY: VALUE OF STATIC VS KINETIC MEASURES OF FLUORODEOXYGLUCOSE UPTAKE

Por Dunnwald, Lisa K., Doot, Robert K., Specht, Jennifer M., Gralow, Julie R., Ellis, Georgiana K., Livingston, Robert B., Linden, Hannah M., Gadi, Vijayakrishna K., Kurland, Brenda F., Schubert, Erin K., Muzi, Mark, Mankoff, David A.
Publicado em 2011

Facility variability in examination indication among women with prior breast cancer: implications and the need for standardization

Por Buist, Diana S.M., Ichikawa, Laura, Wernli, Karen J., Lee, Christoph I., Henderson, Louise M., Kerlikowske, Karla, Bowles, Erin J.A., Miglioretti, Diana L., Specht, Jennifer, Rauscher, Garth, Sprague, Brian, Onega, Tracy, Lee, Janie M.
Publicado no J Am Coll Radiol (2020)

Tumor Metabolism and Blood Flow Changes by Positron Emission Tomography: Relation to Survival in Patients Treated With Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer

Por Dunnwald, Lisa K., Gralow, Julie R., Ellis, Georgiana K., Livingston, Robert B., Linden, Hannah M., Specht, Jennifer M., Doot, Robert K., Lawton, Thomas J., Barlow, William E., Kurland, Brenda F., Schubert, Erin K., Mankoff, David A.
Publicado em 2008

Tumor Metabolism and Blood Flow as Assessed by PET Varies by Tumor Subtype in Locally Advanced Breast Cancer

Por Specht, Jennifer M., Kurland, Brenda F., Montgomery, Susan K., Dunnwald, Lisa K., Doot, Robert K., Gralow, Julie R., Ellis, Georgina K., Linden, Hannah M., Livingston, Robert B., Allison, Kimberly H., Schubert, Erin K., Mankoff, David A.
Publicado em 2010

Fluoroestradiol (FES) Positron Emission Tomography (PET) Reveals Differences In Pharmacodynamics Of Aromatase Inhibitors, Tamoxifen, And Fulvestrant In Patients With Metastatic Bre...

Por Linden, Hannah M., Kurland, Brenda F., Peterson, Lanell M., Schubert, Erin K., Gralow, Julie R., Specht, Jennifer M., Ellis, Georgiana K., Lawton, Thomas, Livingston, Robert B., Petra, Philip H., Link, Jeanne M., Krohn, Kenneth A., Mankoff, David A.
Publicado em 2011

Prospective Study of Serial (18)F-FDG PET and (18)F-Fluoride PET to Predict Time to Skeletal-Related Events, Time to Progression, and Survival in Patients with Bone-Dominant Metast...

Por Peterson, Lanell M., O’Sullivan, Janet, Wu, Qian (Vicky), Novakova-Jiresova, Alena, Jenkins, Isaac, Lee, Jean H., Shields, Andrew, Montgomery, Susan, Linden, Hannah M., Gralow, Julie, Gadi, Vijayakrishna K., Muzi, Mark, Kinahan, Paul, Mankoff, David, Specht, Jennifer M.
Publicado no J Nucl Med (2018)

A Phase II Study of 3′-Deoxy-3′-(18)F-Fluorothymidine PET in the Assessment of Early Response of Breast Cancer to Neoadjuvant Chemotherapy: Results from ACRIN 6688

Por Kostakoglu, Lale, Duan, Fenghai, Idowu, Michael O., Jolles, Paul R., Bear, Harry D., Muzi, Mark, Cormack, Jean, Muzi, John P., Pryma, Daniel A., Specht, Jennifer M., Hovanessian-Larsen, Linda, Miliziano, John, Mallett, Sharon, Shields, Anthony F., Mankoff, David A.
Publicado no J Nucl Med (2015)

Phase I Study of Veliparib (ABT-888) Combined with Cisplatin and Vinorelbine in Advanced Triple-Negative Breast Cancer and/or BRCA Mutation-Associated Breast Cancer

Por Rodler, Eve T., Kurland, Brenda F., Griffin, Melissa, Gralow, Julie R., Porter, Peggy, Yeh, Rosa F., Gadi, Vijayakrishna K., Guenthoer, Jamie, Beumer, Jan H., Korde, Larissa, Strychor, Sandra, Kiesel, Brian F., Linden, Hannah M., Thompson, John A., Swisher, Elizabeth, Chai, Xiaoyu, Shepherd, Stacie, Giranda, Vincent, Specht, Jennifer M.
Publicado no Clin Cancer Res (2016)